<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01888822</url>
  </required_header>
  <id_info>
    <org_study_id>MarPic63</org_study_id>
    <nct_id>NCT01888822</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis in Laparoscopic Cholecystectomy</brief_title>
  <official_title>Ciprofloxacin, Ampicillin-sulbactam and Placebo Prophylaxis in Laparoscopic Cholecystectomy. A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial aims to assess the value of two-regimen antibiotic prophylaxis versus placebo in
      elective laparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients enrolled will be submitted to laparoscopic cholecystectomy. The primary aim of
      the trial will be to assess the role of prophylactic i.v. infusion of ampicillin-sulbactam,
      ciprofloxacin, and placebo to reduce the rate of surgical site infection.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>30 days after operation</time_frame>
    <description>Surgical site infection defined according to the Centre of Disease Control (CDC) classification, recorded as 'yes' or 'no'.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extra-abdominal infections</measure>
    <time_frame>30 days</time_frame>
    <description>Extra-abdominal infections defined according to the CDC classification, recorded as 'yes' or 'no'.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events.</measure>
    <time_frame>30 days</time_frame>
    <description>Adverse events, defined as allergic reactions to antibiotics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>30 days</time_frame>
    <description>Quality of life measured with the 36-Item Short Form Health Survey</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Cholelithiasis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous infusion of 0.9% Sodium Chloride 250 ml during induction of anesthesia and before laparoscopic cholecystectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ampicillin-sulbactam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous infusion of 3gr ampicillin-sulbactam in 0.9% Sodium Chloride 250 ml during induction of anesthesia and before laparoscopic cholecystectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ciprofloxacin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous infusion of 400 mg ciprofloxacin in 0.9% Sodium Chloride 250 ml during induction of anesthesia and before laparoscopic cholecystectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ciprofloxacin</intervention_name>
    <description>Prophylactic ciprofloxacin infusion before elective laparoscopic cholecystectomy</description>
    <arm_group_label>Ciprofloxacin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ampicillin-sulbactam</intervention_name>
    <description>Prophylactic ampicillin-sulbactam infusion before elective laparoscopic cholecystectomy</description>
    <arm_group_label>Ampicillin-sulbactam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Prophylactic placebo infusion before elective laparoscopic cholecystectomy</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective laparoscopic cholecystectomy;

          -  patients suffering from gallbladder stones,chronic cholecystitis, cholesterolosis, or
             gallbladder polyps.

        Exclusion Criteria:

          -  acute cholecystitis;

          -  acute cholangitis;

          -  acute pancreatitis;

          -  pregnant or lactating women;

          -  antibiotic allergy;

          -  antibiotic therapy within 48 hours to 7 days prior to surgery;

          -  clinically active infection at the moment of surgery;

          -  evidence of common bile duct stones;

          -  contraindications for laparoscopic cholecystectomy;

          -  no other additional procedure;

          -  indication of obligatory antibiotic prophylaxis because the medical condition was
             different from biliary disease (immunosuppression, corticoid use, etc).

          -  patients unable to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erasmo Spaziani, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Sapienza University of Rome</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sapienza University of Rome- Polo Pontino</name>
      <address>
        <city>Terracina</city>
        <state>Latina</state>
        <zip>04019</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Sanabria A, Dominguez LC, Valdivieso E, Gomez G. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD005265. doi: 10.1002/14651858.CD005265.pub2. Review.</citation>
    <PMID>21154360</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2013</study_first_posted>
  <last_update_submitted>April 23, 2016</last_update_submitted>
  <last_update_submitted_qc>April 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Erasmo Spaziani</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic cholecystectomy</keyword>
  <keyword>Prophylactic antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Sulbactam</mesh_term>
    <mesh_term>Sultamicillin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

